Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.04 CNY
436.49 M CNY
1.89 B CNY
586.42 M
About JAFRON BIOMEDICAL
Sector
Industry
CEO
Fan Dong
Website
Headquarters
Zhuhai
Founded
1989
ISIN
CNE100002995
FIGI
BBG006FTHNB5
Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. Its products include HA series hemoperfusion cartridge, BS bilirubin adsorption column, DNA immunoadsorption column, hemoperfusion machine, blood purification machine and other products. The company was founded on December 19, 1989 and is headquartered in Zhuhai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 300529 is 29.97 CNY — it has decreased by −0.30% in the past 24 hours. Watch JAFRON BIOMEDICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange JAFRON BIOMEDICAL stocks are traded under the ticker 300529.
300529 stock has fallen by −2.31% compared to the previous week, the month change is a −3.48% fall, over the last year JAFRON BIOMEDICAL has showed a 37.73% increase.
We've gathered analysts' opinions on JAFRON BIOMEDICAL future price: according to them, 300529 price has a max estimate of 42.41 CNY and a min estimate of 42.41 CNY. Watch 300529 chart and read a more detailed JAFRON BIOMEDICAL stock forecast: see what analysts think of JAFRON BIOMEDICAL and suggest that you do with its stocks.
300529 reached its all-time high on May 21, 2021 with the price of 103.00 CNY, and its all-time low was 6.82 CNY and was reached on Aug 2, 2016. View more price dynamics on 300529 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
300529 stock is 2.34% volatile and has beta coefficient of 1.55. Track JAFRON BIOMEDICAL stock price on the chart and check out the list of the most volatile stocks — is JAFRON BIOMEDICAL there?
Today JAFRON BIOMEDICAL has the market capitalization of 23.56 B, it has decreased by −1.55% over the last week.
Yes, you can track JAFRON BIOMEDICAL financials in yearly and quarterly reports right on TradingView.
JAFRON BIOMEDICAL is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
300529 net income for the last quarter is 239.13 M CNY, while the quarter before that showed 267.74 M CNY of net income which accounts for −10.69% change. Track more JAFRON BIOMEDICAL financial stats to get the full picture.
Yes, 300529 dividends are paid annually. The last dividend per share was 0.40 CNY. As of today, Dividend Yield (TTM)% is 1.33%. Tracking JAFRON BIOMEDICAL dividends might help you take more informed decisions.
JAFRON BIOMEDICAL dividend yield was 1.80% in 2023, and payout ratio reached 72.73%. The year before the numbers were 2.16% and 60.09% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 3.29 K employees. See our rating of the largest employees — is JAFRON BIOMEDICAL on this list?
Like other stocks, 300529 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAFRON BIOMEDICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JAFRON BIOMEDICAL technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JAFRON BIOMEDICAL stock shows the neutral signal. See more of JAFRON BIOMEDICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.